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As the access and abilities of technology vastly improves, the use of telehealth in the 
medical setting increases.  While implementing these services, it is important to aim for the 
outcomes for patients to be comparable to the outcomes seen with in-person appointments.  One 
area that telehealth can have an impact is on wheelchair seating and mobility assessments, as there 
are home factors that can influence the selection of a device.  The population using wheeled 
mobility devices can also experience problems traveling to appointments, making telehealth a 
prime alternative.  The purpose of this study is to compare the Functional Mobility Assessment 
(FMA) outcomes of a population of veterans receiving an evaluation using telehealth to a general 
population receiving their assessment in a clinic.  Veterans were initially screened and 
administered the FMA Time 1 on their current device, and then evaluated in their home or place 
of residence using a VA videoconference system.  Then, veterans received a phone call 21 days or 
more after receiving the new device to administer the FMA Time 2, and 27 veterans were reached 
during this follow-up.  To compare the results to an in-person clinical setting, 27 participants were 
selected from a database matching for age, gender, and primary diagnosis.  These participants also 
had Time 1 and Time 2 FMA scores, and the study compared each of the 10 FMA items between 
groups for each time point.  The results showed that there were no statistically significant 
differences between the groups for 7 of 10 FMA items in Time 1 and 6 of 10 FMA items in Time 
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2.  The veteran group showed statistically significant differences in daily routine, personal care, 
and indoor mobility for Time 1 and reach, transfers, personal care, and transportation for Time 2.  
The higher scores for certain items may be due to funding policy differences between the VA and 
non-VA groups.  Overall, the results show that the telehealth group had no statistically significant 
differences in outcomes than the clinic group, and this provides encouragement for more studies 
to be done and assessments to be performed using a telehealth platform. 
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1.0 INTRODUCTION 
1.1 BACKGROUND 
In the United States, there are over 40 million people living with a disability, over 12% of 
the country’s population.  It is also reported that 6.9% of the country classified their disability type 
as “ambulatory”, which was the highest category over visual, hearing, and cognitive (Erickson, 
2019).   In the US population aged 65 years and older, 40% reported at least one disability, and 
two-thirds of them have an issue due to mobility (He, 2014).  When experiencing a lack of 
mobility, older adults face many risks.  These include higher morbidity and mortality, a lower 
quality of life, and isolation from the world and social circles (Gill, 2006).  There is also an 
association between low mobility and all types of social engagement, including using the phone 
and internet, and engagement was even lower when it was outside the home, such as visiting 
friends or recreation centers (Rosso, 2013). 
Telehealth services are increasing in many areas of healthcare, and take on many names: 
telehealth, telerehabilitation, telemedicine, and e-health cover the broad categories, and specific 
names; telecardiology, teleneurology, telepathology, and more for each specialty.  In many fields, 
teleservices are used for early assessments, patient management, and even prevention.  They are 
used to serve parts of the community that do not normally have access to medical services.  These 
areas often have little medical support, and they are often far away from specialized centers.  This 
can result in long travel times for the client due to distance, geography, and transportation options 
(Ekeland, 2010). 
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In telehealth, it is important to consider the outcomes for the patient and balance them with 
the benefits and costs.  While telehealth can save time, travel, and costs for the patient, it could be 
detrimental long-term if the care received is below what would be received at an in-person 
appointment.  It is crucial to collect outcomes from the patient and the clinician, both with 
satisfaction using the telehealth service and the health and functional outcomes of the patient. 
The purpose of this study was to look at the functional outcomes of a group of veterans 
who received a wheeled mobility device through a telehealth assessment compared to a similar 
group that received a device through the traditional in-person clinic assessment outside the veteran 
population.  Both groups completed the Functional Mobility Assessment (FMA) satisfaction 
questionnaire before and after receiving and using their new device. This allowed for comparison 
of functional mobility outcomes pre and post intervention to determine if there is a statistically 
significant difference in outcomes between the methods of assessments. 
1.2 RELATED RESEARCH 
1.2.1  Wheeled Mobility 
When choosing an appropriate device for mobility, there are many factors that affect the 
end user in terms of mobility and outcomes.  The Rehabilitation Engineering and Assistive 
Technology Society of North America (RESNA) Wheelchair Service Provision Guide was created 
to show the essential steps when providing a wheelchair.  It considers important factors including 
the current technology used, environment, support system activity, participation, body functions 
and structures, and the goals of the client (Arledge et al, 2011).  When it comes to the goals of the 
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client, there is a risk of abandonment if they are given a device to use where they had little input 
(Batavia 2001).  In terms of body structures and function, setting up a manual wheelchair to a 
user’s dimensions and comfort with propelling a chair will impact their function.  A study by 
Boninger et. al (2000) found that the axle position of the wheelchair relative to the user’s shoulder 
can affect injury to the upper limb, and proper positioning can improve the propulsion 
biomechanics and reduce the risk of injury.  In a population of users in assisted living facilities, 
the users often use foot propulsion as a method of moving their chair around their room.  This can 
be affected by the seat height and the footrests, and it is important to find out the goals of the user 
and propulsion method in order to accommodate their needs and improve their mobility (Suzuki, 
2012). 
There are also users who need much more support in their seating system.  If the user is 
unable to support their trunk and upper body, a custom seating system needs to be considered 
(Lange 2018).  If they are not able to relieve pressure by themselves, a dynamic seating component 
is considered to allow the user to tilt in space (Sprigle 2014).  Furthermore, the RESNA Position 
Paper on the Application of Tilt, Recline, and Elevating Legrests for Wheelchairs (Dicianno, 2015) 
indicates that positioning features are important to consider when selecting a device to treat, 
alleviate, or prevent complications such as posture, edema, pressure, comfort, and spasticity.  
When these systems are implemented in a chair, information and training must be provided to the 
user to ensure the proper use and results. 
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1.2.2  Functional Mobility Assessment (FMA) 
The Functional Mobility Assessment (FMA) is a self-reported outcome tool that measures 
the user’s satisfaction with performing daily tasks and activities while considering all types of 
mobility.  The FMA was created from a modified version of the Functioning Everyday with a 
Wheelchair (FEW) tool, which asked about satisfaction of performing tasks while using a 
wheelchair, but leaves out other mobility such as canes, crutches, prosthetics, or using no device 
(Mills, 2002).  Since the FEW only concerned wheelchairs, it was found to be unreliable to use 
when asking users who are transitioning from a non-wheelchair mobility device to a wheelchair 
(Kumar, 2013).  From testing in the study performed by Kumar et al, the FMA was found to have 
a high intra-class correlation coefficient (ICC = 0.87), whereas the FEW had an ICC = 0.86.   
Items of the FMA satisfaction questionnaire ask about most of the factors that are 
considered in the RESNA Wheelchair Provision Guide, in a very short questionnaire.  The 
questions start with “My current means of mobility” to be inclusive of all devices (or no device), 
and asks the following 10 items: 
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Table 1.  FMA Items and Abbreviations 
My current means of mobility… Abbreviation 
Allows me to carry out my daily routine as 
independently, safely, and efficiently as possible Daily Routine 
Meets my comfort needs Comfort 
Meets my health needs Health 
Allows me to operate it as independently, safely, and 
efficiently as possible Operate 
Allows me to reach and carry out tasks at different 
surface heights as independently, safely, and 
efficiently as possible 
Reach 
Allows me to transfer from one surface to another Transfers 
Allows me to carry out personal care task Personal Care 
Allows me to get around indoors Indoor Mobility 
Allows me to get around outdoors Outdoor Mobility 
Allows me to use personal or public transportation 
independently, safely, and efficiently as possible Transportation 
  
These items are answered on a scale of 1 to 6, from completely disagree to completely 
agree.  The FMA is asked over time as well, which allows the observation of change in function 
over a period of time, including when a new device is received.  
The FMA has improved on the older version, the FEW, by simplifying the wording of the 
questions, and changing them to ask about a user’s current means of mobility, which includes all 
types of mobility.  It has received an excellent test-retest and is known as a reliable tool to 
determine a user’s satisfaction with a mobility device over multiple time points (Kumar, 2013).  
Studies have also shown that outcome tools like the Wheelchair Outcome Measure can be 
practical, reliable, and have good test-retest reliability when collected over the phone (Auger, 
2010). 
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1.2.3  Telehealth Benefits  
A systematic review of telehealth and satisfaction (Krowski, 2017) found that the biggest 
factors contributing to the use were improved outcomes, preferred modality, ease of use, lowered 
cost, and decreased travel time.  One of the largest benefits to conducting a telehealth assessment 
for wheeled mobility in a client’s home is that the home assessment can take place at the same 
time.  During a normal wheelchair assessment in clinic, the client sees a specialist, usually a 
physical therapist, occupational therapist, assistive technology professional, and/or a physician.  
Then they are recommended a device to try out.  The procedure after initial assessment is to have 
the supplier visit the client’s home with the device to evaluate accessibility such as home entry, 
floors, and door width, and then they order the equipment for delivery and a final fitting.  With 
telehealth, the home evaluation can be completed by the Telehealth Clinical Technician (TCT’s), 
measurements can be taken, the device can even be test-driven in the house, and ordered all in one 
appointment.  This allows a one-stop visit where the clinician, TCT’s, the client, and their family 
can appropriately see and demonstrate the way the device will be used in that setting, and many 
issues can be immediately tested. 
 Another benefit is the saved time for both the veteran and the provider.  In settings 
such as the Veteran’s Administration Medical Center, the seating clinician would travel to a 
veteran’s home if the veteran was unable to make it to the clinic.  This takes extra time before and 
after the appointment, and they would book just one appointment that morning or afternoon.  Using 
the telehealth system, the appointment took up a normal amount of the clinician’s time (60 to 90 
minutes).  There could be two telehealth appointments scheduled per day:  one in the morning and 
one in the afternoon (Grenier, 2018).  During the time the TCT’s travel between the two telehealth 
sites, the clinician can continue to see clients at their regular in-person clinic. 
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Telehealth has shown to reduce costs to the patient and the medical system as well.  Studies 
have shown that using telehealth methods to perform assessments and monitor patients has 
decreased the number of hospital stays and emergency room visits (Noel, 2004).  A systematic 
review of 36 studies found that telehealth was less costly in 61%, equally as costly in 9%, and 
costlier in 31%.  Meanwhile, the outcomes were improved or similar to traditional care in 91% of 
the studies (Wade, 2010).  They commented that telehealth was most effective for home care, on-
call specialists, and rural service delivery, while not as effective for service in hospitals and 
primary care. 
Telehealth services can serve communities that lack access to specialized medical fields. 
With rural parts of the country, there is a lack of specialized care facilities and physicians, and if 
that care is needed, they must travel to larger cities.  Travel from rural communities can take hours, 
especially dependent on the weather, traffic, and geography, and missed appointments are 
burdensome to both the patient and the system.  Implementing telehealth in these communities 
allows access to these services in the home or at local medical centers, where a combination of 
nurse care and telehealth communication with a specialist can be used (Nelson, 2017).  According 
to the Pennsylvania State Legislature, there are 48 rural counties in PA (less than 284 persons per 
square mile), which equates to 27% of the state’s population.  These counties also contain a higher 
population of people over 65 years old, and implementing these telehealth systems to the region 
will increase the care (Rural/ Urban PA, 2010). 
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1.2.4  User Satisfaction with Telehealth 
Even with all the benefits that telehealth modalities offer, a large factor in whether or not 
the system should be used is the user satisfaction.  Telehealth increases the range of services 
available while they decrease the burden of cost and travel on the user.   
To measure the satisfaction of users of telehealth, surveys are used to gather data on 
different parts of telehealth. In a previous study performed using telehealth between an expert 
clinician and four remote wheelchair clinics set up at least 125 miles away, Schein, Schmeler, and 
Saptono (2010) found that the patients accepted the use of telehealth and reported significantly 
higher scores (past the scales mid-point) per the Telerehabilitation Questionnaire (TRQ). The TRQ 
was also measured during the home telehealth evaluations that were performed for Grenier’s study.   
The veterans had a high satisfaction of all aspects of the telehealth process and would use it again 
over clinical appointments (Grenier, 2018).  While this could be from a satisfaction based on the 
convenience of telehealth, the high satisfaction scores have been shown in several studies.  The 
providers also marked significantly high scores with the telehealth process; their lowest scoring 
item was due to the quality and clarity of the platform.  While the veterans were highly satisfied 
with the quality and clarity, this particular item would be more important for the clinician.  The 
veteran only needs to see the clinician’s face and hear the clinician’s voice, while the clinician 
must see the client clearly while they are being evaluated, especially when it comes to fitting the 
veteran.  While there was a significant difference between the veteran and provider TRQ, they 
were almost all within one point on the TRQ, where the difference could be from mostly satisfied 
to completely satisfied (Grenier 2018). 
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1.2.5  Telehealth Issues 
One of the main costs of using telehealth is in fact the monetary expense for using TCT’s 
out in the field.  Compared to an in-person clinical setting, there is the added costs of the TCT’s 
wage, a van, gas, parking, extra tools, the device (tablet), cellphone, mobile data device, and the 
mobile data plan.  While this cost can be high for doing mobility assessments, the impact can be 
minimized by using the telehealth staff for other appointments.  There is also the benefit of the 
clinician being able to stay in the clinic for other appointments versus driving. 
Telehealth can also face some issues with the ability of the client to use the technology.  
Some telehealth modalities require some technology experience from the user to access the video 
calls.  This experience can vary, and often times an older population has less experience with using 
the platform.  In the paper by Grenier (2018), the issues faced during this study are detailed further, 
including the personal connection and strength of connection. 
1.2.6  Telehealth Outcomes 
Using traditional outcome measures to determine if a significant difference between 
telehealth groups and a clinical setting has been tested in several studies. A study evaluated the 
Functional Independence Measure  (FIM) scores between telerehabilitation and standard care over 
six months for those with a spinal cord injury.  They found no significant difference between the 
two intervention types and any clinical complications, and improvements on the FIM scores in the 
telerehabilitation group in the areas of grooming, dressing and transfers (Dallolio, 2008). 
Another study (Schein et al., 2010) closely related to the current study was performed using 
the Functioning Everyday with a Wheelchair (FEW) outcome measure, and relating an in clinic 
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setting with telehealth performed at several offsite locations for wheelchair and seating 
evaluations.  There were no significant differences in FEW scores during the pretest, and no 
significant differences in FEW scores for the post-test except for transportation, where telehealth 
had a slightly lower score.  They also looked at the clinically significant difference of 1.85, the 
only two items to not reach the significance was in-person transfer and telerehabilitation 
transportation (Schein et al., 2010). 
1.2.7  VA Telehealth Services 
The Department of Veterans Affairs’ (VA) runs the largest healthcare system in the United 
States, with over 9 million veterans enrolled, and they are seen at 172 medical centers and over 
1,000 outpatient clinics (U.S. Department of Veterans Affairs, 2016).  With a high population of 
veterans that live in rural areas (45% of telehealth recipients in the VA), the VA develops, tests, 
and implements new telehealth services to ensure all veterans are receiving a high quality of care.  
There are three modalities of telehealth that are used by the VA: 
• Clinical Video Telehealth (CVT) – real-time video conferencing to assess and treat 
a patient remotely 
• Home Telehealth (HT) – using in-home technology to monitor patients and manage 
their conditions 
• Store and Forward Telehealth (SFT) – information is stored and then sent to or 
retrieved by a provider at a later time  
In 2016, the VA had over 700,000 veterans using a form of telehealth, which 45% of were 
living in rural communities that were determined to have low access to VA healthcare.  There are 
also 900 locations using the telehealth services and are offered in 50 specialties.  The veterans are 
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screened and are allowed to continue regular care if requested, but many are continuing use of 
telehealth.  The veterans are also satisfied with the system; veterans are 88%-94% satisfied with 
the telehealth technologies, and when following patients using these services, they are witnessing 
a 59% decrease in the VA bed days of care (U.S. Department of Veterans Affairs, 2016).   
 
1.2.8  VA Wheeled Mobility Telehealth Process 
To conduct wheelchair seating and mobility appointments using the VA Telehealth 
platform and CVT, a team of Telehealth Clinical Technicians (TCTs) were recruited.  A TCT had 
to meet several characteristics; knowledge of wheelchair seating and mobility, ability to operate 
the technology used and diagnose any issues that may arise, a driver’s license to travel to the 
appointments, and other TCT requirements.  The team had multiple wheeled mobility devices; a 
Quickie 2 wheelchair, a scooter, and a group 3 power wheelchair as devices for clients to try, as 
they cover the three main areas of wheeled mobility.  For the telehealth system, an electronic tablet 
was connected to the internet via a mobile hotspot, with two carriers available in case one had a 
poor signal.  Other equipment included a tool kit to make adjustments, measurement tools, a 
portable ramp for loading the van and entering a veteran’s home if a step was present, a light to 
brighten the video, and information on the products.  To determine if a telehealth visit would be 
used for a wheelchair assessment, the original consult and veteran’s medical record was reviewed 
to determine location, diagnosis, and transportation.  If they met the criteria, a TCT contacted the 
veteran by phone to evaluate home accessibility, internet connection information, willingness to 
receive the appointment via telehealth, collect the pre-visit assessment containing the Uniform 
Dataset (UDS) and the Functional Mobility Assessment Time 1 (FMA T1), and then an 
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appointment was scheduled.  The TCT’s would then travel to the veteran’s home with the 
telehealth equipment and wheeled mobility devices, connect to the VA Wheelchair Clinic, and the 
TCT’s conducted the evaluation according to the directions from the Teleprovider.  The 
Teleprovider completed the documentation and submits the order, and the veteran would receive 
the device in clinic or at the home, where the TCT’s would conduct the final fitting via telehealth.  
Twenty-one days or more after the device was received by the veteran, the TCT called the veteran 
to conduct the Functional Mobility Assessment Time 2 (FMA T2).  A flowchart of this process 
can be found in the Appendix A (Grenier, 2018). 
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2.0 METHODS 
2.1 INTRODUCTION 
The research project that this study is based on was a project that looked to reduce the 
problems in accessing wheeled mobility devices in a veteran population by creating a telehealth 
method of wheelchair assessments in the rural Pittsburgh area, and conducting the assessments on 
those veterans while collecting data.  The assessments were based out of the VA Pittsburgh 
Aspinwall seating clinic and used a team of TCT’s to travel to the veteran’s homes.  There were 
several metrics that were used to measure outcomes of the assessments, including the Functional 
Mobility Assessment and associated Uniform Dataset (FMA/UDS), the Telerehabilitation 
Questionnaire (TRQ), and the Quebec User Evaluation of Satisfaction with Technology (QUEST).  
These are commonly used tools when measuring the satisfaction and outcomes of wheelchair 
seating and mobility interventions and services. 
The FMA/UDS outcomes management system and registry is a strategy developed 
between the University of Pittsburgh and US Rehab that comprises a nationwide network of 
mobility equipment providers (Schmeler et al., 2019). US Rehab providers collect baseline 
FMA/UDS and at set times following provision of a mobility device to monitor progress, accrue 
large data, perform Quality Assurance, and conduct research on the effectiveness of device 
interventions and service delivery models. 
This study specifically evaluated the FMA scores of veterans who received new device 
through the telehealth program at the VA clinic pre-appointment and post-delivery of the new 
device.  Since the VA does not typically collect FMA/UDS as part of routine wheelchair service 
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delivery, VA telehealth data was compared to matched cases in the FMA/UDS registry. While 
there are differences between the VA and non-VA groups, the study helps to see if receiving an 
assessment using telehealth has a significant difference from an in-person assessment.  Showing 
similar scores in both settings is important before larger projects and studies are conducted on 
telehealth in the seating and mobility sector.  To show this, there are two hypotheses tested: there 
is no difference at Time 1 to show the groups are at similar starting mobility, and Time 2 to show 
both groups report the same satisfaction with their new device.  These tests were run on each of 
the 10 FMA items to determine if specific needs were not being met.  The hypotheses are as 
follows: 
• Null Hypothesis 1: There will be no statistically significant difference in the FMA 
T1 scores between veterans who are receiving a device from the VA Telehealth and 
clients who are receiving their device from the clinic. 
• Null Hypothesis 2: There will be no statistically significant difference in the FMA 
T2 scores between veterans who are receiving a device from the VA Telehealth and 
clients who are receiving their device from the clinic. 
2.2 STUDY DESIGN 
           
 The study was a retrospective analysis of data collected from two independent databases.  
The first was a deidentified database from the VA Telehealth project, where 27 individuals passed 
the inclusion criteria (having both Time 1 and Time 2 FMA scores).  The second database is from 
providers across the United States, and 27 individuals were chosen from this source based on 
 15 
matching age, gender, and primary diagnosis.  The two independent groups were assigned as the 
Telehealth (TH) group and the Clinic (CL) group.  The matching was performed on these variables 
to remove them as potential confounding variables.  While matching on current device at Time 1 
and Time 2 would help to remove the possibility that the device chosen was not directly influencing 
the FMA scores, this would severely restrict the sample size given a starting point of 27 veterans.   
The matching was performed first by searching the FMA/UDS registry for all matching 
cases on primary diagnosis.  Then, a list of birth year for both the veteran group and clinic group 
was formed for that diagnosis, and all perfect matches were paired.  If there was no exact match 
for birth year, the range would extend on year earlier and later until a match was formed.  In most 
cases, an exact year was matched. 
For each group, the FMA scores were collected by a person trained on administering the 
FMA.  The Clinic group had Time 1 (T1) scores collected in clinic, and the Time 2 (T2) scores in 
clinic, over the phone, or by letter.  With the Telehealth group, T1 scores were collected over the 
phone or in-person, while T2 scores were collected during a follow-up phone call.  Both groups 
had the T2 scores collected no less then 21 days post-delivery in order for the user to have spent 
time using the device and getting acclimated to use.   
Both the FMA scores and the other important demographics were placed into an Excel 
sheet where the participants could be compared on different variables.  The data was also sorted 
in IBM SPSS Statistics 25, where descriptive and inferential statisticswere performed. 
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2.3 PARTICIPANTS 
The participants were used from two databases: from the VA Telehealth study data and 
from a national de-identified FMA/UDS dataset.  To be selected from the VA Telehealth study, 
users must have met the following criteria: 
• FMA T1 was complete 
• FMA T2 was complete 
• Veteran was evaluated completely using telehealth 
To be selected from the FMA/UDS dataset, cases must have met the following criteria: 
• FMA T1 was complete 
• FMA T2 was complete 
• Matched with a veteran based on age, gender, and primary diagnosis 
• Client was seen by an Assistive Technology Professional for evaluation 
 For this study, there were 27 matched pairs formed (n = 54).  There were 43 veterans seen 
during the telehealth project, but there were 16 without Time 2 FMA scores due to not using the 
new device, passing away, or not answering/returning follow-up calls, leaving 27 veterans.  
Twenty-seven clients from the national FMA/UDS registry (n = 2029) were selected based on 
inclusion criteria, and matched to the VA group based on gender, primary diagnosis, and age.  For 
some of the cases pulled from the FMA/UDS registry, some items were answered “Does Not 
Apply” thus lowered the sample size for certain items.  This can further lower the power in 
detecting if a change was there between the two groups.  A table of the number of responses can 
be found in Appendix B. 
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2.4 INSTRUMENTATION 
The instrument used in this study is the Functional Mobility Assessment (FMA), and the 
tool was administered at two time points: Time 1 (T1) and Time 2 (T2).  Time 1 was related to 
their current means of mobility, and Time 2 was administered at least 21 days after receiving their 
new mobility device.  In the telehealth group, the FMA was conducted by students in the 
Rehabilitation Science and Technology program who were trained in administering the tool, and 
were conducted over the phone before the appointment for Time 1 and by phone at least 21 days 
after for Time 2.  For the clinic data set, the questions were performed by providers who received 
training.  The FMA consists of a 10 item questionnaire regarding satisfaction in performing 
mobility related activities of daily living that is answered as follows: 
1 = Completely Disagree 
2 = Mostly Disagree 
3 = Somewhat Disagree 
4 = Somewhat Agree 
5 = Mostly Agree 
6 = Completely Agree 
The maximum score that can be reported on the tool is 60.  The lowest score can be a 10, but there 
is an option for each statement on the tool that is ‘Does Not Apply’, which then lowers the total 
possible score.  For example, if the client reports ‘Does Not Apply’ for one question, the maximum 
score would be out of 54.  During this study, the FMA comparisons were broken down by each of 
the 10 items; therefore, a change can be observed based on certain items versus just the total score. 
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2.5 PROCEDURES 
The data was de-identified from VA Telehealth an FMA/UDS datasets and both contained 
the UDS and FMA Time 1 and Time 2.    The matching cases that met the inclusion criteria were 
added to the Excel document. This spreadsheet contained the demographics for each subject and 
their FMA Time 1 and Time 2 scores.  The FMA data included each score out of 6, and then the 
sum out of 60.  It was kept separated by each item on the FMA, and Excel worksheets were made 
for Time 1, Time 2, and change in score per person.  These worksheets were used to calculate the 
mean and standard deviation of the telehealth group and the clinic group for each item, and then 
the data was exported to IBM SPSS Statistics 25 to be analyzed. 
2.6 DATA ANALYSIS 
The data analysis was done using IBM SPSS Statistics 25.  All alpha levels during this 
study were set to α = 0.05 for all tests. The mean age of the groups was tested using an independent 
samples t-test, as age was normally distributed for both groups.  The demographics of primary 
device at Time 1 and Time 2 were compared between groups using a Chi Squared Goodness of Fit 
Test.  In cases where the sample size was too small for the chi square test, Fisher’s exact test was 
performed. 
For analyzing the FMA scores between groups, the tests were split up to compare each 
FMA item between Telehealth and Clinic.  This was done for both Time 1 and Time 2, yielding 
20 tests.  Since the FMA uses ordinal (ranked) data, the Mann-Whitney U test was chosen as it is 
the nonparametric equivalent of an independent t-test.  The effect size and power were calculated 
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post-hoc using G*Power 3.1.9.2 for each item using the mean, standard deviation, and sample 
sizes from the data. 
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3.0 RESULTS 
3.1 DEMOGRAPHICS 
There were 54 total participants in this analysis.  For some FMA items, the group size was 
less than 27 due to participants answering ‘Does Not Apply’, and the group size can be seen in 
Appendix B.  Gender and primary diagnosis were a perfect match between groups.    The ages 
reported for the two groups were TH = 81.63 ± 8.58, and for CL = 79.93 ± 9.14.  The mean of the 
ages was found to be not significant (t = .706, p = .483).  For the current primary device, the types 
of device were no device, transport chair, cane/crutches/walker, POV/scooter, K0001/K0002, 
K0003/K0004, K0005, K0009/not coded, group 1 power wheelchair, group 2 power wheelchair, 
group 3 power wheelchair, and group 4 power wheelchair.  There was no significant difference 
between these devices (p = .074).  See Table 2 for all demographic information. 
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Table 2. Demographics 
 Telehealth (TH  Clinic (CL) Z p* 
Demographic N = 27 N = 27   
Age (Mean ± SD)  81.63 ± 8.58 79.93 ± 9.14 .706 (t) .483 
Gender (n, %) 
     Male 
     Female  
    
27 (100%) 
0 (0%) 
    
27 (100%) 
0 (0%) 
 
 
 
 
Primary Diagnosis (n, %) 
     Amputation  
     Cardiopulmonary  
     Osteoarthritis  
     Other Neuromuscular 
     Parkinson Disease 
     SCI (tetra/quad)  
     Stroke/CVA  
    
2 (7.4%) 
3 (11.1%) 
5 (18.5%) 
8 (29.6%) 
1 (3.7%) 
1 (3.7%) 
7 (25.9%) 
 
2 (7.4%) 
3 (11.1%) 
5 (18.5%) 
8 (29.6%) 
1 (3.7%) 
1 (3.7%) 
7 (25.9%) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Current Primary Device 
     No Device 
     Transport Chair 
     Cane/Crutches/Walk 
     POV/Scooter 
     K0001/K0002 
     K0003/K0004 
     K0009/Not Coded 
     Group 1 Power 
     Group 2 Power 
     Group 3 Power  
   
1 (3.7%) 
1 (3.7%) 
12 (44.4%) 
0 (0.0%) 
0 (0.0%) 
8 (29.6%) 
0 (0.0%) 
0 (0.0%) 
1 (3.7%) 
4 (14.8%) 
   
2 (7.4%) 
0 (0.0%) 
10 (37.0%) 
1 (3.7%) 
2 (7.4%) 
1 (3.7%) 
1 (3.7%) 
1 (3.7%) 
6 (22.2%) 
3 (11.1%) 
 
.074 
 
 
 
 
 
 
 
 
 
 
Device at Time 2    .001 
     Transport Chair 
     K0003/K0004 
     K0005 Ultralight 
     Tilt-in-Space 
     Group 1 Power 
     Group 2 Power 
     Group 3 Power 
     Group 4 Power 
1 (3.7%) 
0 (0.0%) 
10 (37.0%) 
2 (7.4%) 
1 (3.7%) 
0 (0.0%) 
12 (44.4%) 
1 (3.7%) 
0 (0.0%) 
1 (3.7%) 
1 (3.7%) 
0 (0.0%) 
0 (0.0%) 
12 (0.0%) 
13 (48.1%) 
0 (0.0%) 
  
p*< 0.05     
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3.2 FMA TIME 1 
Looking at the tests for Time 1 (Table 2), there was no significant difference between 
FMA scores on seven of the items: Comfort (Z = -1.877, p = .061), Health (Z = -1.366, p = 
.172), Operate (Z = -1.576, p = .115), Reach (Z = -.047,  p = .962), Transfers (Z = -.799, p = 
.424), Outdoor (Z = -.733, p = .464), and Transportation (Z = -.087, p = .931).  The telehealth 
group scored significantly higher in Daily Routine (Z = -2.029, p = .042), Personal Care (Z = -
2.528, p =.011), and Indoor (Z = -2.688, p = .007). 
Table 3. Time 1 Telehealth and Clinic Mann-Whitney U Test 
 
 Telehealth FMA Clinic FMA Z p* 
FMA Item N = 27 N = 27^   
Daily Routine 3.56 (1.91) 2.44 (1.76) -2.029 .042 
Comfort 3.26 (1.72) 2.46 (1.96) -1.877 .061 
Health 3.33 (1.80) 2.69 (1.87) -1.366 .172 
Operate 3.67 (1.82) 2.81 (1.92) -1.576 .115 
Reach 2.89 (1.85) 2.92 (1.89) -.047 .962 
Transfers 3.93 (1.62) 3.46 (1.79) -.799 .424 
Personal Care 4.11 (1.67) 2.88 (1.64) -2.528 .011 
Indoor 4.44 (1.40) 3.11 (1.78) -2.688 .007 
Outdoor 2.00 (1.54) 2.44 (1.85) -.733 .464 
Transportation 3.30 (1.98) 3.21 (1.69) -.087 .931 
p*< 0.05    ^See Appendix B for Group Size 
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Figure 1.  Time 1 Mean FMA Scores 
3.3 FMA TIME 2 
For the Time 2 comparison (Table 3), there was no significant difference between the 
FMA scores on 6 items: Daily Routine (Z = -.931, p = .352), Comfort (Z = -1.310, p = .190), 
Health (Z = -1.495, p = .135), Operate (Z = -1.416, p = .157), Indoor (Z = -.215, p = .830), and 
Outdoor (Z = -.795, p = .427).  The telehealth group scored significantly higher on Reach (Z = -
2.195, p = .028), Transfers (Z = -3.381, p = .001), Personal Care (Z = -2.242, p = .025), and 
Transportation (Z = -2.048, p = .041). 
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Table 4. Time 2 Telehealth and Clinic Mann-Whitney U Test 
 
 Telehealth FMA Clinic FMA Z p* 
FMA Item N = 27 N = 27^   
Daily Routine 5.59 (0.69) 4.89 (1.85) -.931 .352 
Comfort 5.52 (1.09) 4.93 (1.82) -1.310 .190 
Health 5.81 (0.62) 5.15 (1.79) -1.495 .135 
Operate 5.70 (0.67) 5.00 (1.75) -1.416 .157 
Reach 5.56 (0.97) 4.70 (1.81) -2.195 .028 
Transfers 5.93 (0.27) 4.93 (1.66) -3.381 .001 
Personal Care 5.74 (0.86) 4.89 (1.93) -2.242 .025 
Indoor 5.78 (0.42) 5.44 (1.37) -.215 .830 
Outdoor 5.52 (0.85) 4.81 (1.90) -.795 .427 
Transportation 5.56 (0.97) 4.31 (2.15) -2.048 .041 
p*< 0.05    ^See Appendix B for Group Size 
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4.0 DISCUSSION 
4.1 NULL HYPOTHESIS 1 
The null hypothesis for Time 1 FMA was accepted for seven of the ten FMA items, and 
was rejected for the following items: daily routine, personal care, and indoor mobility.  It was 
expected that the scores would be similar across all areas, as Time 1 scores were before the 
implementation of telerehabilitation.  This shows that for most of the FMA items, there is little to 
no difference between the VA group and the people receiving devices in the clinic.  The few scores 
that showed a statistically significant difference could be due to the difference in the providers or 
funding, as 48% of veterans from the VA group received their original device from the VA.  In all 
three cases, the VA group had the higher mean, showing a higher satisfaction with their device.  
The Indoor item also had a large effect size, with the standard deviation greater than 0.8 (Appendix 
E).  The other items had a medium effect size, except for transportation, which had a small effect 
size.   
4.2 NULL HYPOTHESIS 2 
The null hypothesis for the Time 2 FMA was accepted for six of the ten items, and it was 
rejected for the following items: reach, transfers, personal care, and transportation.  With 6 of the 
10 items being similar, it shows that the Telehealth method had no real change from the clinic 
method of assessment.  In the four cases that showed a statistically significant difference, the VA 
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group had significantly higher satisfaction with their devices.  Since they received the device from 
the VA, their scores such as reach and transfer could be higher due to the VA providing seat 
elevators; seven of the veterans received a seat elevator at Time 2 compared to only two subjects 
in the clinic group.  Studies have also shown that seat elevators do have an impact on these FMA 
times (Schiappa, 2016).  Transfers also had a high effect size, over 0.8 standard deviations 
(Appendix E).  All other items had a medium effect size.  The VA will also make sure a veteran 
can get a lift added to their vehicle if necessary, which increases their satisfaction with 
transportation (four of the veterans received a vehicle lift between Time 1 and Time 2, while there 
was no change in transportation for the clinic group). 
4.3 CHANGE IN FMA SCORES 
 
In some cases, the change in FMA score was larger in the Clinic group vs the Telehealth 
group.  These included routine, personal care, and indoor mobility.  This would primarily be due 
to the Telehealth group having significantly higher scores in these areas during Time 1; they had 
much less room to increase.  The Telehealth group had a larger change in height, outdoor mobility, 
and transportation, which were also three areas they had significantly higher Time 2 scores when 
compared to the clinic group.   
Overall, fifteen out of the twenty items reached an increase of 1.85 or above.  This number 
(1.85) was used in a study on telehealth assessments using the Functioning Everyday with a 
Wheelchair scale to represent a clinically significant change (Schein et al, 2010); there is no such 
number for the FMA, but the FMA is a modified version of the FEW, so some comparison can be 
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made.  All but personal care and indoor mobility were clinically significant for the Telehealth 
group, and these two items were significantly higher than the Clinic group during Time 1, so there 
was less room for change over time.  For the clinic setting, reach, transfers, and transportation did 
not reach 1.85.  This could again be due to the lack of funding for seat elevators and vehicle lifts, 
both of which often come as out of pocket costs to the client.  Therefore, they would not see 
improvements in these areas compared to the veterans. 
 
 
Figure 3. Mean Change in FMA Scores 
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outside of the VA System.  There are differences in the settings, mainly with the funding of the 
devices, the options for the client, and the quality of care.  The VA system does not have a database 
of the demographics and FMA scores from their users over time, so a comparison could not be 
made in the same health system.  From the sample, the veterans had a higher satisfaction with their 
current means of mobility, and also finished with higher changes in score relating to their outdoor 
mobility and their reach.  With the VA as a funding source, outdoor mobility is also considered 
when selecting a device.  Through Medicare and some other insurance policies (used in the clinic 
setting), they are mostly concerned with inside the home, and Medicare’s coverage specifically 
states, “for use in home” (Medicare, Wheelchair Insurance Coverage).  During our telehealth 
appointments, some were focused on finding the veteran an option for a device to use outside the 
home as well as inside (one group 4 power wheelchair was provided for the telehealth group). 
 The sample for this study may also have an effect on the study.  Since the veteran 
group was all males, they were matched with males from the clinic group.  An all-male sample is 
not representative of the population, which could lead to a bias based on gender.  This was due to 
the convenience sampling of the study, where no females were eligible.  There was also a low 
sample size which reduces the power of the study, and influences whether it can detect an effect if 
there is one (Appendix C).  This can lead to a higher chance of Type II error, where the hypothesis 
is confirmed when an alternative is true. 
The higher level of evaluation received may also be a limit to the study.  The FMA/UDS 
Registry includes evaluations performed from a range of professionals, from Assistive Technology 
Professionals (ATP’s), clinicians, and suppliers.  While all cases had an ATP present, the telehealth 
group had one ATP/clinician on the video call, and two or more TCT’s who were trained student 
in the field.  This would cause more viewpoints during an evaluation and given that the telehealth 
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group was assessed in the home while the other group could be in clinic, in home, or another 
location, the device chosen for the user could be better based on the home and use case. 
There was a statistically significant difference between the type of device received at Time 
2 that may have been a confounding factor in the study.  While the difference in device could cause 
a difference in the FMA scores, matching on Time 2 device on top of the other matched factors 
would yield a smaller sample size.  During an evaluation, a device is chosen on many factors, and 
even when matching on age, gender, and diagnosis, the appropriate device for each subject could 
be different.   
Another limitation with the study can be the presence of the ceiling effect.  With the FMA 
Time 2 scores being recorded between one to three months after receiving the device, the 
participants had answers that were very high, which makes it difficult to detect a significant 
difference between groups even if there is one.  There FMA is designed to show satisfaction of the 
device, and during this study investigators compared the end of the life cycle and the very 
beginning of the new device.  While they were all satisfied with the device, the purpose of this 
study was to demonstrate that there were no statistically significant differences between the 
groups. 
Finally, there might be a limitation due to using convenience sampling to find the veterans 
to use telehealth.  There were selection criteria, but the veteran was offered to try the telehealth 
assessment in their home.  Some veterans were close enough that they normally could make it to 
clinic, but several would never receive the device without a telehealth assessment due to travel 
limitations.  They may report higher satisfaction with the device because they received a new 
device, when the increase in score may not be with the mobility.  This might be a problem with 
telehealth services, as people may be satisfied that they are receiving care they normally would 
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not have access to.  However, the FMA is targeted around the devices and mobility, and their 
comments for items match what is to be expected based on their score.  
4.5 FUTURE WORK 
To further conduct research on this topic, it would be beneficial to continue receiving FMA 
scores from the telerehabilitation group long term.  With the clinic data, there are often FMA scores 
that are asked over multiple points of the life of the device (typically 5 years) which can show a 
greater change in satisfaction.  Having multiple time points for the FMA scores could show a 
change in the satisfaction over months or years, and then a difference between telehealth and 
traditional clinic settings could be shown, as a comparison could be made between new devices 
and the FMA scores a few years after receiving the device.  The VA could also implement the 
FMA/UDS, which would allow comparisons within similar funding/provider systems, and would 
increase the sample size for future studies. 
Changing the setting of the study could also provide useful results.  The study could be 
carried out in various clinics across the United States and expand the population of users with 
devices received through telerehabilitation.  Their continued follow-up appointments and new 
devices could be received through telehealth appointments, and a better idea of the telehealth affect 
on the satisfaction with the devices could be proven. 
As technology expands and increases in quality, telehealth can branch out into many 
different fields.  There can be uses for this platform in different areas of assistive technology; 
computer access, mobility, home accessibility, home automation, sports and recreation, and more 
veterans can be assessed and treated through telehealth platforms.  
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4.6 CONCLUSION 
Using telerehabilitation is becoming popular in many fields of healthcare and is used to 
increase the access to care and the information available for users.  Wheelchair seating and 
mobility is an area of healthcare that affects many different parts of a person’s daily routine, and 
improper mobility is a barrier to accessing health services.  Using telehealth as a way to assess 
clients for an appropriate device can increase the population receiving devices, and can also be a 
method of performing the evaluation, home assessment, and device trial in one meeting.  Both 
the users and clinicians were satisfied with using the telerehabilitation platform, and this study 
shows that the people receiving their device through telerehabilitation showed no statistically 
significant differences with their mobility compared to a group receiving their device in a clinic.  
The study also found that the telerehabilitation group was experiencing the same clinically 
significant change in FMA score between Time 1 and Time 2 that the clinical population saw.  
Telerehabilitation for mobility assessments is an option for those who can not make the trip into 
the clinic that will match the process of receiving a device in a clinic, and it can have monetary 
savings for both the clinic and the user. 
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Appendix A Telehealth Process Flowchart 
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Appendix B Group Size 
Table 5. Time 1 Group Size 
 
Table 6. Time 2 Group Size 
 
 FMA Item Telehealth N Clinic N 
Daily Routine 27 27 
Comfort 27 26 
Health 27 26 
Operate 27 27 
Reach 27 25 
Transfers 27 26 
Personal Care 27 25 
Indoor 27 27 
Outdoor 27 27 
Transportation 27 24 
   
 FMA Item Telehealth N Clinic N 
Daily Routine 27 27 
Comfort 27 27 
Health 27 27 
Operate 27 27 
Reach 27 27 
Transfers 27 27 
Personal Care 27 27 
Indoor 27 27 
Outdoor 27 27 
Transportation 27 26 
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Appendix C Effect Size and Power 
Table 7. Time 1 Effect Size and Power 
 
Table 8. Time 2 Effect Size and Power 
 
 
FMA Item Effect Size Power 
Daily Routine 0.61 0.57 
Comfort 0.43 0.33 
Health 0.35 0.23 
Operate 0.46 0.37 
Reach 0.02 0.05 
Transfers 0.27 0.16 
Personal Care 0.74 0.73 
Indoor 0.83 0.83 
Outdoor 0.25 0.14 
Transportation 0.05 0.05 
   
 
FMA Item Effect Size Power 
Daily Routine 0.50 0.42 
Comfort 0.39 0.28 
Health 0.49 0.41 
Operate 0.53 0.46 
Reach 0.59 0.55 
Transfers 0.84 0.84 
Personal Care 0.57 0.52 
Indoor 0.34 0.22 
Outdoor 0.48 0.40 
Transportation 0.75 0.74 
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